Reply to letter: "RE: Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity: an observational study".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

1. Effects of obstructive sleep apnea on non-alcoholic fatty liver disease in patients with obesity: a systematic review.International journal of obesity (2005) · 2023
   Pooled it
2. Updating obesity management strategies: an audit of Italian specialists.Eating and weight disorders : EWD · 2022
   Article
3. RE: Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity-an observational study.Eating and weight disorders : EWD · 2022
   Article

Corrections and comments

• Comment on
  RE: Association of obstructive sleep apnea with non-alcoholic fatty liver disease in patients with obesity-an observational study.2022

Authors and funding

2 authors at 1 institution in 1 country.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as